Skip to main content
Erschienen in: Journal of Gastroenterology 4/2011

01.04.2011 | Original Article—Liver, Pancreas, and Biliary Tract

Alcohol drinking patterns and the risk of fatty liver in Japanese men

verfasst von: Yasunari Hiramine, Yasushi Imamura, Hirofumi Uto, Chihaya Koriyama, Masahisa Horiuchi, Makoto Oketani, Kaori Hosoyamada, Ken Kusano, Akio Ido, Hirohito Tsubouchi

Erschienen in: Journal of Gastroenterology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Alcohol is considered to be a major cause of fatty liver (FL). In contrast, however, recent investigations have suggested that moderate alcohol consumption is protective against FL. To clarify the role of alcohol consumption in FL development, we examined the association between drinking patterns and FL prevalence.

Methods

We enrolled 9,886 male participants at regular medical health checks. Each subject’s history of alcohol consumption was determined by questionnaire. The subjects were classified according to alcohol consumption as non-, light, moderate, and heavy drinkers (0, <20, 20–59, and ≥60 g/day, respectively). FL was defined by ultrasonography. Independent predictors of FL were determined by logistic regression analysis.

Results

The prevalence of FL displayed a “U-shaped curve” across the categories of daily alcohol consumption (non-, 44.7%; light, 39.3%; moderate, 35.9%; heavy drinkers, 40.1%; P < 0.001). The prevalence of FL was associated positively with body mass index and other obesity-related diseases and inversely with alcohol consumption (light, odds ratio [OR] 0.71, 95% confidence interval [CI] 0.59–0.86; moderate, OR 0.55, CI 0.45–0.67; heavy, OR 0.44, CI 0.32–0.62) as determined by multivariate analysis after adjusting for potential confounding variables. In addition, examination of drinking patterns (frequency and volume) revealed that the prevalence of FL was inversely associated with the frequency of alcohol consumption (≥21 days/month) (OR 0.62, CI 0.53–0.71) but not with the volume of alcohol consumed.

Conclusions

Our observations suggest that alcohol consumption plays a protective role against FL in men, and consistent alcohol consumption may contribute to this favorable effect.
Literatur
1.
Zurück zum Zitat Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–61.PubMedCrossRef Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–61.PubMedCrossRef
2.
Zurück zum Zitat Eguchi Y, Eguchi T, Mizuta T, Mizuta T, Ide Y, Yasutake T, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462–9.PubMedCrossRef Eguchi Y, Eguchi T, Mizuta T, Mizuta T, Ide Y, Yasutake T, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462–9.PubMedCrossRef
3.
Zurück zum Zitat Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y, et al. Association between changes in body composition and the increasing prevalence of fatty liver in Japanese man. Hepatol Res. 2008;38:1083–6.PubMedCrossRef Imamura Y, Uto H, Oketani M, Hiramine Y, Hosoyamada K, Sho Y, et al. Association between changes in body composition and the increasing prevalence of fatty liver in Japanese man. Hepatol Res. 2008;38:1083–6.PubMedCrossRef
4.
Zurück zum Zitat Kitajima Y, Eguchi Y, Ishibashi E, Nakashita S, Aoki S, Toda S, et al. Age-related fat deposition in multifundus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol. 2010;45:218–24.PubMedCrossRef Kitajima Y, Eguchi Y, Ishibashi E, Nakashita S, Aoki S, Toda S, et al. Age-related fat deposition in multifundus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol. 2010;45:218–24.PubMedCrossRef
5.
Zurück zum Zitat Kojiro M, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M, et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45:86–94.CrossRef Kojiro M, Nishiguchi S, Aoyagi Y, Hiasa Y, Tokumoto Y, Onji M, et al. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol. 2010;45:86–94.CrossRef
6.
Zurück zum Zitat Siler SQ, Neese RA, Hellersein MK. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in human after acute alcohol consumption. Am J Clin Nutr. 1999;70:923–36. Siler SQ, Neese RA, Hellersein MK. De novo lipogenesis, lipid kinetics, and whole-body lipid balances in human after acute alcohol consumption. Am J Clin Nutr. 1999;70:923–36.
7.
Zurück zum Zitat You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004;287:1–6.CrossRef You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004;287:1–6.CrossRef
8.
Zurück zum Zitat Donohue TM Jr. Alcohol-induced steatosis in liver cell. World J Gastroenterol. 2007;15:1178–85.CrossRef Donohue TM Jr. Alcohol-induced steatosis in liver cell. World J Gastroenterol. 2007;15:1178–85.CrossRef
9.
Zurück zum Zitat Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver diseases: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.PubMedCrossRef Dixon JB, Bhathal PS, O’Brien PE. Nonalcoholic fatty liver diseases: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology. 2001;121:91–100.PubMedCrossRef
10.
Zurück zum Zitat Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol. 2007;102:1912–9.PubMedCrossRef Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol. 2007;102:1912–9.PubMedCrossRef
11.
Zurück zum Zitat Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology. 2008;47:1947–54.PubMedCrossRef Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology. 2008;47:1947–54.PubMedCrossRef
12.
Zurück zum Zitat Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104:2189–95.PubMedCrossRef Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104:2189–95.PubMedCrossRef
13.
Zurück zum Zitat Yamada T, Fukatsu M, Suzuki S, Yoshida T, Tokudome S, Joh T. Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci. 2010;55:176–82.PubMedCrossRef Yamada T, Fukatsu M, Suzuki S, Yoshida T, Tokudome S, Joh T. Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci. 2010;55:176–82.PubMedCrossRef
14.
Zurück zum Zitat Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267–73.PubMedCrossRef Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267–73.PubMedCrossRef
15.
Zurück zum Zitat Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and morality among women. N Engl J Med. 1995;332:1245–50.PubMedCrossRef Fuchs CS, Stampfer MJ, Colditz GA, Giovannucci EL, Manson JE, Kawachi I, et al. Alcohol consumption and morality among women. N Engl J Med. 1995;332:1245–50.PubMedCrossRef
16.
Zurück zum Zitat Gaziano JM, Burning JE, Berslow JL, Goldhaber SZ, Rosner B, VanDenvurgh M, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829–34.PubMedCrossRef Gaziano JM, Burning JE, Berslow JL, Goldhaber SZ, Rosner B, VanDenvurgh M, et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med. 1993;329:1829–34.PubMedCrossRef
17.
Zurück zum Zitat Tsumura K, Hayashi T, Suematsu C, Endo G, Fujii S, Okada K. Daily alcohol consumption and the risk of type 2 diabetes in Japanese men. Diabetes Care. 1999;22:1432–7.PubMedCrossRef Tsumura K, Hayashi T, Suematsu C, Endo G, Fujii S, Okada K. Daily alcohol consumption and the risk of type 2 diabetes in Japanese men. Diabetes Care. 1999;22:1432–7.PubMedCrossRef
18.
Zurück zum Zitat Wei L, Gibbons LW, Mitchell TL, Kampert JB, Blair SN. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care. 2000;23:18–22.PubMedCrossRef Wei L, Gibbons LW, Mitchell TL, Kampert JB, Blair SN. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care. 2000;23:18–22.PubMedCrossRef
19.
Zurück zum Zitat Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.PubMedCrossRef Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylor PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.PubMedCrossRef
20.
Zurück zum Zitat Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040–4.PubMed Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, et al. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040–4.PubMed
21.
Zurück zum Zitat Sierksma A, Patel H, Ouchi N, Kihara S, Funahasi T, Heine RJ, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-α, and insulin sensitivity. Diabetes Care. 2004;27:184–9.PubMedCrossRef Sierksma A, Patel H, Ouchi N, Kihara S, Funahasi T, Heine RJ, et al. Effect of moderate alcohol consumption on adiponectin, tumor necrosis factor-α, and insulin sensitivity. Diabetes Care. 2004;27:184–9.PubMedCrossRef
22.
Zurück zum Zitat Conigrave M, Hu FB, Camargo CA, Stampher MJ, Willett W, Rimm EB. A prospective study of drinking patterns in relation to risk of type 2 diabetes among men. Diabetes. 2001;50:2390–5.PubMedCrossRef Conigrave M, Hu FB, Camargo CA, Stampher MJ, Willett W, Rimm EB. A prospective study of drinking patterns in relation to risk of type 2 diabetes among men. Diabetes. 2001;50:2390–5.PubMedCrossRef
23.
Zurück zum Zitat Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–18.PubMedCrossRef Mukamal KJ, Conigrave KM, Mittleman MA, Camargo CA Jr, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–18.PubMedCrossRef
24.
Zurück zum Zitat You M, Fischer M, Matsumoto M, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002;277:29342–7.PubMedCrossRef You M, Fischer M, Matsumoto M, Crabb DW. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP). J Biol Chem. 2002;277:29342–7.PubMedCrossRef
25.
Zurück zum Zitat Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional activation of peroxisome proliferators-activated receptor α is inhibited by ethanol metabolism: novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem. 2001;276:68–75.PubMedCrossRef Galli A, Pinaire J, Fischer M, Dorris R, Crabb DW. The transcriptional activation of peroxisome proliferators-activated receptor α is inhibited by ethanol metabolism: novel mechanism for the development of ethanol-induced fatty liver. J Biol Chem. 2001;276:68–75.PubMedCrossRef
26.
Zurück zum Zitat You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004;127:1798–808.PubMedCrossRef You M, Matsumoto M, Pacold CM, Cho WK, Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology. 2004;127:1798–808.PubMedCrossRef
27.
Zurück zum Zitat Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol. 2003;163:1137–46.PubMedCrossRef Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol. 2003;163:1137–46.PubMedCrossRef
28.
Zurück zum Zitat Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008;38:1122–9.PubMedCrossRef Higuchi N, Kato M, Shundo Y, Tajiri H, Tanaka M, Yamashita N, et al. Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease. Hepatol Res. 2008;38:1122–9.PubMedCrossRef
29.
Zurück zum Zitat Sanal MG. The blind men ‘see’ the elephant–the many faces of fatty liver disease. World J Gastroenterol. 2008;14:831–44.PubMedCrossRef Sanal MG. The blind men ‘see’ the elephant–the many faces of fatty liver disease. World J Gastroenterol. 2008;14:831–44.PubMedCrossRef
30.
Zurück zum Zitat Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46–54.PubMedCrossRef Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology. 2004;40:46–54.PubMedCrossRef
31.
Zurück zum Zitat Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53:3218–24.PubMedCrossRef Sazci A, Akpinar G, Aygun C, Ergul E, Senturk O, Hulagu S. Association of apolipoprotein E polymorphisms in patients with non-alcoholic steatohepatitis. Dig Dis Sci. 2008;53:3218–24.PubMedCrossRef
32.
Zurück zum Zitat Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology. 2009;50:772–80.PubMedCrossRef Fujita K, Nozaki Y, Wada K, Yoneda M, Fujimoto Y, Fujitake M, et al. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology. 2009;50:772–80.PubMedCrossRef
33.
Zurück zum Zitat Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemelä OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr. 2008;88:1097–103.PubMed Alatalo PI, Koivisto HM, Hietala JP, Puukka KS, Bloigu R, Niemelä OJ. Effect of moderate alcohol consumption on liver enzymes increases with increasing body mass index. Am J Clin Nutr. 2008;88:1097–103.PubMed
34.
Zurück zum Zitat Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet. 2002;47:333–41.PubMedCrossRef Saheki T, Kobayashi K. Mitochondrial aspartate glutamate carrier (citrin) deficiency as the cause of adult-onset type II citrullinemia (CTLN2) and idiopathic neonatal hepatitis (NICCD). J Hum Genet. 2002;47:333–41.PubMedCrossRef
35.
Zurück zum Zitat Imamura Y, Kobayashi K, Shibatou T, Abrada S, Tahara K, Kubozono O, et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res. 2003;26:68–72.PubMedCrossRef Imamura Y, Kobayashi K, Shibatou T, Abrada S, Tahara K, Kubozono O, et al. Effectiveness of carbohydrate-restricted diet and arginine granules therapy for adult-onset type II citrullinemia: a case report of siblings showing homozygous SLC25A13 mutation with and without the disease. Hepatol Res. 2003;26:68–72.PubMedCrossRef
Metadaten
Titel
Alcohol drinking patterns and the risk of fatty liver in Japanese men
verfasst von
Yasunari Hiramine
Yasushi Imamura
Hirofumi Uto
Chihaya Koriyama
Masahisa Horiuchi
Makoto Oketani
Kaori Hosoyamada
Ken Kusano
Akio Ido
Hirohito Tsubouchi
Publikationsdatum
01.04.2011
Verlag
Springer Japan
Erschienen in
Journal of Gastroenterology / Ausgabe 4/2011
Print ISSN: 0944-1174
Elektronische ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-010-0336-z

Weitere Artikel der Ausgabe 4/2011

Journal of Gastroenterology 4/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Antikörper mobilisiert Neutrophile gegen Krebs

03.06.2024 Onkologische Immuntherapie Nachrichten

Ein bispezifischer Antikörper formiert gezielt eine Armee neutrophiler Granulozyten gegen Krebszellen. An den Antikörper gekoppeltes TNF-alpha soll die Zellen zudem tief in solide Tumoren hineinführen.

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.